These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38678133)

  • 1. Prenatal exposure to environmental contaminants and cord serum metabolite profiles in future immune-mediated diseases.
    Karthikeyan BS; Hyötyläinen T; Ghaffarzadegan T; Triplett E; Orešič M; Ludvigsson J
    J Expo Sci Environ Epidemiol; 2024 Apr; ():. PubMed ID: 38678133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cord serum metabolic signatures of future progression to immune-mediated diseases.
    Hyötyläinen T; Karthikeyan BS; Ghaffarzadegan T; Triplett EW; Orešič M; Ludvigsson J
    iScience; 2023 Mar; 26(3):106268. PubMed ID: 36915680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Environmental Exposures on Human Breast Milk Lipidome in Future Immune-Mediated Diseases.
    Hyötyläinen T; Ghaffarzadegan T; Karthikeyan BS; Triplett E; Orešič M; Ludvigsson J
    Environ Sci Technol; 2024 Feb; 58(5):2214-2223. PubMed ID: 38263945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease.
    Sen P; Qadri S; Luukkonen PK; Ragnarsdottir O; McGlinchey A; Jäntti S; Juuti A; Arola J; Schlezinger JJ; Webster TF; Orešič M; Yki-Järvinen H; Hyötyläinen T
    J Hepatol; 2022 Feb; 76(2):283-293. PubMed ID: 34627976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal exposure to poly-/per-fluoroalkyl substances is associated with alteration of lipid profiles in cord-blood.
    Sinisalu L; Yeung LWY; Wang J; Pan Y; Dai J; Hyötyläinen T
    Metabolomics; 2021 Nov; 17(12):103. PubMed ID: 34816353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure to persistent organic pollutants alters the serum metabolome in non-obese diabetic mice.
    Sinioja T; Bodin J; Duberg D; Dirven H; Berntsen HF; Zimmer K; Nygaard UC; Orešič M; Hyötyläinen T
    Metabolomics; 2022 Nov; 18(11):87. PubMed ID: 36329300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Signatures of the Exposome-Quantifying the Impact of Exposure to Environmental Chemicals on Human Health.
    Orešič M; McGlinchey A; Wheelock CE; Hyötyläinen T
    Metabolites; 2020 Nov; 10(11):. PubMed ID: 33182712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to legacy and novel perfluoroalkyl substance disturbs the metabolic homeostasis in pregnant women and fetuses: A metabolome-wide association study.
    Li Y; Lu X; Yu N; Li A; Zhuang T; Du L; Tang S; Shi W; Yu H; Song M; Wei S
    Environ Int; 2021 Nov; 156():106627. PubMed ID: 33991873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal trajectories and determinants of plasma per- and polyfluoroalkyl substance (PFAS) levels from birth to early childhood and metabolomic associations: A pilot study in the Boston Birth Cohort.
    Zhang M; Yu CH; Wang G; Buckley JP; Hong X; Pearson C; Adams WG; Fan ZT; Wang X
    Precis Nutr; 2022 Jun; 1(1):. PubMed ID: 36936201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-targeted metabolomics and associations with per- and polyfluoroalkyl substances (PFAS) exposure in humans: A scoping review.
    Guo P; Furnary T; Vasiliou V; Yan Q; Nyhan K; Jones DP; Johnson CH; Liew Z
    Environ Int; 2022 Apr; 162():107159. PubMed ID: 35231839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of environmental metabolism disrupting chemicals and effect biomarkers associating disease risks: Where exposomics meets metabolomics.
    Sun J; Fang R; Wang H; Xu DX; Yang J; Huang X; Cozzolino D; Fang M; Huang Y
    Environ Int; 2022 Jan; 158():106941. PubMed ID: 34689039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-life exposure to perfluorinated alkyl substances modulates lipid metabolism in progression to celiac disease.
    Sinisalu L; Sen P; Salihović S; Virtanen SM; Hyöty H; Ilonen J; Toppari J; Veijola R; Orešič M; Knip M; Hyötyläinen T
    Environ Res; 2020 Sep; 188():109864. PubMed ID: 32846648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine metabolome profiling of immune-mediated inflammatory diseases.
    Alonso A; Julià A; Vinaixa M; Domènech E; Fernández-Nebro A; Cañete JD; Ferrándiz C; Tornero J; Gisbert JP; Nos P; Casbas AG; Puig L; González-Álvaro I; Pinto-Tasende JA; Blanco R; Rodríguez MA; Beltran A; Correig X; Marsal S;
    BMC Med; 2016 Sep; 14(1):133. PubMed ID: 27609333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Metabolomics Identifies Altered Bioenergetics, Signaling Cascades in Parallel with Exposome Markers in Crohn's Disease.
    Lai Y; Xue J; Liu CW; Gao B; Chi L; Tu P; Lu K; Ru H
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30691236
    [No Abstract]   [Full Text] [Related]  

  • 15. Investigating the early metabolic fingerprint of celiac disease - a prospective approach.
    Kirchberg FF; Werkstetter KJ; Uhl O; Auricchio R; Castillejo G; Korponay-Szabo IR; Polanco I; Ribes-Koninckx C; Vriezinga SL; Koletzko B; Mearin ML; Hellmuth C
    J Autoimmun; 2016 Aug; 72():95-101. PubMed ID: 27323936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk analysis of serum chemical residues for metabolic associated fatty liver disease based on exposome-lipidome wide association study].
    Chen QQ; You L; Guan PW; Fang CN; Qin WS; Liu XY; Xu GW
    Se Pu; 2024 Feb; 42(2):164-175. PubMed ID: 38374597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
    Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between the Maternal Exposome and Metabolome during Pregnancy.
    Chen M; Guan Y; Huang R; Duan J; Zhou J; Chen T; Wang X; Xia Y; London SJ
    Environ Health Perspect; 2022 Mar; 130(3):37003. PubMed ID: 35254863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum metabolome by gas chromatography-mass spectrometry (GC-MS) in patients with ulcerative colitis and celiac disease].
    Sitkin SI; Tkachenko EI; Vakhitov TIa; Oreshko LS; Zhigalova TN
    Eksp Klin Gastroenterol; 2013; (12):44-57. PubMed ID: 24933989
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.